CD8A and neoplasm: These results indicate that MBTA vaccine therapy, when implemented in an approach as we present here, has the potential to generate an endogenous innate inflammatory response directed at irradiated tumor cells conjugated to MBTA, which generates numerous immunogenic epitopes that stimulate APCs and results in the generation of a stable, specific, and adaptive CD8+ cytotoxic T lymphocyte anti-neoplastic response.